Orphan drug market set for major growth by 2024
The orphan drug market is expected to increase at a 12% compound annual growth rate (CAGR) to reach $224bn by … read more »
Japan: Open for Business
Japan has made concerted efforts to improve its investment climate, with deregulation of approval pathways and health databases helping to … read more »
Prediction of pharma market slowdown in China and Japan
According to IQVIA’s recent report on global pharmaceutical trends, the thriving markets of Japan and China could be set to … read more »
Pharmaceutical and chemical R&D expenditure grows again in Germany
For the seventh year in a row, expenditure on R&D by the German pharmaceutical and chemical industry has grown, reaching … read more »
